Use of bisphosphonates in chronic kidney disease is associated with cardiovascular death
Contrary to our hypothesis, bisphosphonate use was associated with a trend toward increased incident CVD and a two-fold higher risk of CVD mortality in CKD.
Authors
- Kathleen Borghoff
- Melissa L. Swee (ORCID: https://orcid.org/0000-0002-1591-0862)
- Saket R. Girotra (ORCID: https://orcid.org/0000-0002-4784-4513)
- Amal Shibli‐Rahhal (ORCID: https://orcid.org/0000-0003-2405-8963)
- Patrick Ten Eyck (ORCID: https://orcid.org/0000-0002-5041-0708)
- Diana I. Jalal (ORCID: https://orcid.org/0000-0002-1975-8650)
- Agnes Ounda
- Anna Jovanovich
Publication Details
- Journal
- Clinical Nephrology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.5414/cn111428
- Citations
- 2
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57